product summary
Loading...
company name :
OriGene
product type :
antibody
product name :
Msr1 Rat Monoclonal Antibody [Clone ID: 2F8]
catalog :
SM029R
quantity :
100 Tests
price :
579 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
2F8
reactivity :
mouse
application :
flow cytometry
more info or order :
product information
SKU :
SM029R
Category :
Antibodies
Sub-Category :
Primary Antibodies
Name :
Msr1 Rat Monoclonal Antibody [Clone ID: 2F8]
Description :
Msr1 rat monoclonal antibody, clone 2F8, PE
Size :
100 Tests
Price US :
579 USD
Delivery Time US :
5 Days
Symbol :
Msr1
Uniprot ID :
P30204
Accn :
NP_001106797.1
Clonality :
Monoclonal
Clone Name :
2F8
Host :
Rat
Isotype :
IgG2b
Applications :
FC
Reactivity :
Mouse
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
browse more products
- Cd44 Mouse Monoclonal Antibody [Clone ID: 5035-41.1D] | SM030F
- Cd44 Mouse Monoclonal Antibody [Clone ID: 5035-41.1D] | SM030FT
- Cd44 Mouse Monoclonal Antibody [Clone ID: 5035-41.1D] | SM030FX
- Cd44 Mouse Monoclonal Antibody [Clone ID: 5035-41.1D] | SM030P
- CD45 / LCA Rat Monoclonal Antibody [Clone ID: YW 62.3] | SM032F
questions and comments